Furthermore, Ito et al. observed differences in IGF2 DMR0 methylation between colorectal tumors and adjacent normal tissue but not in peripheral blood of patients with and without colorectal cancer in an unrelated population, using a threshold of ≤35% methylation to classify hypomethylation. This evidence concerns the gene IGF2 and colorectal cancer.